Biomarker Research Advances Early Disease Detection

Researchers are studying chemical signatures or biomarkers to improve early diagnosis of neurological conditions like Alzheimer's and Parkinson's.

While blood and cerebrospinal fluid tests show promise for detecting protein changes, experts emphasize that accuracy and affordability remain significant challenges.

A large study at the Institute of Advanced Virology is currently analyzing biomarkers in 2,000 dengue patients to predict disease complications.